Details for New Drug Application (NDA): 208954
✉ Email this page to a colleague
The generic ingredient in MESALAMINE is mesalamine. There are twenty-eight drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the mesalamine profile page.
Summary for 208954
Tradename: | MESALAMINE |
Applicant: | Zydus Pharms |
Ingredient: | mesalamine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 208954
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MESALAMINE | mesalamine | CAPSULE, EXTENDED RELEASE;ORAL | 208954 | ANDA | Zydus Pharmaceuticals USA Inc. | 68382-452 | 68382-452-19 | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-452-19) |
MESALAMINE | mesalamine | CAPSULE, EXTENDED RELEASE;ORAL | 208954 | ANDA | Zydus Lifesciences Limited | 70771-1625 | 70771-1625-7 | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1625-7) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 375MG | ||||
Approval Date: | Aug 12, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription